Biotech Essentials

Biotech & Healthcare

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 13.05.2021.

Vaccination
Health care
Medicine
Vaccine
Balance sheet
Managing director

Healthcare

@Biotechnology shared
On May 7, 2021
BioSpace Movers & Shakers, May 7 https://t.co/6HxUKfU9Pv https://t.co/dEY2GJbZBy
Open
BioSpace Movers & Shakers, May 7

BioSpace Movers & Shakers, May 7

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

@JaredSHopkins shared
On May 12, 2021
BioNTech’s success in coming up with the West’s first Covid-19 vaccine is drawing attention from investors looking to invest in search of the next hidden gem in German biotech https://t.co/ZPtuSHItD6 via @WSJ
Open
BioNTech’s Covid-19 Vaccine Success Sparks Investments in German Biotech

BioNTech’s Covid-19 Vaccine Success Sparks Investments in German Biotech

After the company partnered with Pfizer on a vaccine, investors last year poured $3.7 billion into a sector that has struggled to raise funding in recent years.

@jonathanrockoff shared
On May 11, 2021
Here’s what scientists know about the new coronavirus variant B.1.617, first identified in India, which the World Health Organization has designated a global “variant of concern,” by ⁦@sarahtoy17⁩ and ⁦@wsj_douglasj⁩ https://t.co/Tk0HkCkD0Z
Open
The Covid-19 Variant in India: What Scientists Know About the B.1.617 Strain

The Covid-19 Variant in India: What Scientists Know About the B.1.617 Strain

The new coronavirus variant, first identified in India, has been designated a global “variant of concern” by the World Health Organization.

@BIODeutschland shared
On May 12, 2021
MorphoSys and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-line Treatment for Diffuse Large B-Cell Lymphoma https://t.co/HVYsYwn2VD
Open
First-line Treatment for Diffuse Large B-Cell Lymphoma

First-line Treatment for Diffuse Large B-Cell Lymphoma

Media Release MorphoSys and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a PLANEGG/MUNICH, Germany and WILMINGTON, Del., …

@GalapagosGlobal shared
On May 6, 2021
Press Release | Galapagos announces its Q1 results and presents refocused pipeline. Read the press release here https://t.co/lzjPHKB3pN https://t.co/x2LEo6AXNv
Open
Galapagos refocuses pipeline and rightsizes operations

Galapagos refocuses pipeline and rightsizes operations

First three months 2021 financial results: Group revenues and other income of €124.2 millionOperating loss of €50.8 millionNet profit of €9.4...

@LionelREICHARDT shared
On May 11, 2021
Sprout Health Solutions and Takeda Explore Digital Health Tools in Rare Disease During Covid-19 https://t.co/QgsepTFuAP https://t.co/eYA4XFI1SY
Open
Sprout Health Solutions and Takeda Explore Digital Health Tools in Rare Disease During Covid-19

Sprout Health Solutions and Takeda Explore Digital Health Tools in Rare Disease During Covid-19

/PRNewswire/ -- Sprout Health Solutions Limited, a global consultancy specializing in behavior science and health outcomes, has partnered with...

@JNJInnovation shared
On May 10, 2021
Staying up-to-date with healthcare trends is important within our industry, as they influence our approach to innovation. 📈 Discover @nerida_scott’s thoughts on the key shifts in the healthcare space and how they’ve impacted our collaborations here: https://t.co/w0pBZOY0rs https://t.co/UXchezATp1
Open
by Johnson & Johnson Innovation

by Johnson & Johnson Innovation

At this year’s BIO-Europe Spring Digital, I had a great discussion with Paul Tunnah, Founder

@ABPI_UK shared
On May 7, 2021
RT @BHPComms: 🔬Accelerating #DrugDiscovery: @unibirmingham has joined a new industry collaborative with @Evotec and Bristol Myers Squibb, which aims to fast-track the therapies of the future from lab to patient > https://t.co/r0c1ATFVDw @RuthRoberts42 @UoBAccelerate https://t.co/6YNRHxABGd
Open
University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb

University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb

Evotec, together with Bristol-Myers Squibb Company (NYSE: BMY) launched beLAB1407, a new $20m academic BRIDGE to identify and advance novel and breakthrough drug discovery …